Isotypic monitoring of anticardiolipin antibodies and pregnancies at risk;SURVEILLANCE ISOTYPIQUE DES ANTICORPS ANTI-CARDIOLIPIDES ET GROSSESSES A RISQUE

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 26, Issue SUPPL. 3, 1997, Pages 164-165

  Barbarino Monnier, P ^a   Gobert, B ^b   Ribon, A M ^a   Schweitzer, M ^a   Faure, G C ^b   Bene M C ^b  

^a Maternite Regionale Universitaire   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; FEMALE; FETUS; HIGH RISK POPULATION; HUMAN; IMMUNOLOGICAL MONITORING; PATIENT MONITORING; PREGNANCY; PREGNANCY DISORDER;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS;

EID: 0030698713     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Harris EN, Baguley E, Asherson RA, Hugues GRV. Clinical and serological features of the « antiphospholipid syndrome ». Br J Rheumatol 1987; 26 (suppl. 2):19.
2. Kaider BD, Price DE, Roussev RG, Coulam CB. Antiphospho-lipid antibody prevalence in patients with IVF failure. Am J Reprod Immunol 1996;35:388-93.
3. MacLean MA, Gumming GP, McCall F, Walker ID, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 1994;101:103-6.
4. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet. Gynecol 1995;86:555-9.
5. Silver RM, Porter TF, Van Leeuween I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies : clinical consequences of « low titers ». Obstet Gynecol 1996;87:494-500.
6. Kwak JYH, Barini R, Gilman-Sachs A, Beaman K.D, Beer A.E. Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome. Am J Obstet Gynecol 1994;171:239-46.
7. Hirashima Y, Kurimoto M, Tsukamoto E, Endo S, Takaku A. Anti-phospholipid antibodies and cerebral vasospasm following subarachnoid haemorrhage. Acta Neurochir 1995;135:191-7.
8. Sachse C, Luthke K, Hartung K, Fricke M, Liedvogel B, Kalden JR, Peter HH, Lakomek HJ, Henkel E, Deicher H. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus : clinical and laboratory associations. The SLE Study Group. Rheumatol. Int 1995;15:23-9.
9. Kennedy M, Jackson J, Khan I, Keeling PW, Gaffney E. Catastrophic anti-phospholipid syndrome in the absence of IgG anticardiolipin antibodies. Scand. J Rheumatol 1995;24:389-91.
10. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983:i:1361-3.
11. Out HJ, Bruinse HW, Derksen R. Antiphospholipid antibodies and pregnancy loss. Hum. Reprod 1991;6:889-97.
12. Sanchez-Guerrero J, Alarcon-Segovia D. Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients. J Rheumatol 1992;19:1083-8.